Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Biocon has informed that the Management of the Company is participating in the Investor Conferences as per the details enclosed. The Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.